Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-17-001108
Filing Date
2017-02-03
Accepted
2017-02-03 21:18:18
Documents
1
Period of Report
2017-02-01

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3974
  Complete submission text file 0001493152-17-001108.txt   5608
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 437 S HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address
BOLL ANDREW R. (Reporting) CIK: 0001542150 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35814 | Film No.: 17573943